Global Interventional Cardiology and Peripheral Vascular Devices Market Size By Type (Angioplasty Balloons, Catheters), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2...

The Global Interventional Cardiology and Peripheral Vascular Devices Market was valued at USD 17.4 billion in 2023 and is projected to reach USD 30.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The rising incidence of cardiovascular diseases, aging populations, and the increasing adoption of minimally invasive procedures are major factors driving market growth. Advancements in device technology, such as drug-eluting stents, atherectomy systems, and next-generation guidewires, are enhancing procedural outcomes and expanding the application scope of interventional procedures.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

Globally, cardiovascular diseases (CVDs) remain the leading cause of mortality, spurring the demand for interventional cardiology and peripheral vascular solutions. The growing burden of atherosclerosis, coronary artery disease, and peripheral artery disease (PAD) is fueling device adoption.

2. Technological Advancements in Devices:

The continuous evolution of stent technology (bioabsorbable, drug-eluting), balloons (scoring and drug-coated), and atherectomy devices is significantly improving procedural success rates, patient recovery times, and long-term outcomes.

3. Aging Population and Sedentary Lifestyle:

An aging global population and lifestyle-related factors such as poor diet, smoking, and lack of exercise are accelerating the incidence of vascular conditions, increasing the demand for interventional procedures.

Restraints:

1. High Procedural and Device Costs:

The high cost of advanced interventional devices and procedures, particularly in low- and middle-income countries, can hinder widespread adoption.

2. Risk of Complications and Device Failures:

Despite technological progress, risks such as restenosis, thrombosis, and procedural complications can affect both patient outcomes and healthcare provider preferences.

Opportunity:

1. Emerging Markets in Asia-Pacific and Latin America:

Countries such as China, India, and Brazil are experiencing significant healthcare infrastructure expansion and rising awareness of cardiac health, presenting untapped growth potential.

2. Integration with Digital Health Technologies:

The incorporation of artificial intelligence (AI), robotics, and imaging systems in vascular interventions is opening new avenues for precision and personalized treatment strategies.

Market by System Type Insights:

Coronary Stents held the largest market share in 2023, driven by their widespread application in treating coronary artery disease. The segment includes bare-metal stents, drug-eluting stents, and bioresorbable stents. Among these, drug-eluting stents have shown dominant growth due to their superior clinical outcomes and reduced risk of restenosis.

On the peripheral side, angioplasty balloons and atherectomy devices are gaining momentum, particularly in the management of peripheral artery disease.

Market by End-use Insights:

Hospitals and Cardiac Centers represented the largest end-use segment in 2023, attributed to the high volume of cardiovascular procedures conducted in these facilities. These centers are equipped with specialized catheterization labs and skilled professionals, making them the preferred choice for complex interventional treatments.

Ambulatory Surgical Centers (ASCs) are anticipated to grow rapidly due to shorter patient stays, cost advantages, and improved patient throughput.

Market by Regional Insights:

North America led the global market in 2023, accounting for the largest revenue share. The region benefits from advanced healthcare infrastructure, high patient awareness, favorable reimbursement policies, and the presence of leading device manufacturers.

Asia-Pacific is expected to experience the highest growth rate during the forecast period due to increasing healthcare spending, government initiatives, and a growing burden of lifestyle-related cardiovascular conditions.

Competitive Scenario:

Prominent players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, B. Braun Melsungen AG, Cordis (Cardinal Health), Biotronik SE & Co. KG, and BD (Becton, Dickinson and Company). Key strategies involve technological innovation, geographic expansion, and M&A activities.

Recent Developments:

March 2024: Medtronic received FDA approval for its next-gen drug-coated balloon designed for below-the-knee peripheral artery disease treatments.

November 2023: Boston Scientific launched a new portfolio of bioresorbable vascular scaffolds for complex coronary interventions in Europe.

June 2023: Abbott introduced an AI-powered platform to assist cardiologists in real-time during coronary angioplasty procedures.

Scope of Work – Global Interventional Cardiology and Peripheral Vascular Devices Market

Report Metric Details

Market Size (2023) USD 17.4 billion

Projected Market Size (2031) USD 30.1 billion

CAGR (2023–2031) 7.1%

Market Segments By System Type (Stents, Balloons, Guidewires, Atherectomy Devices),

By End-use (Hospitals, ASCs, Specialty Clinics),

By Region

Growth Drivers Rising CVD prevalence, device innovation, minimally invasive procedures

Opportunities Emerging markets, digital health integration

Key Market Developments:

2024: Boston Scientific launched new bioresorbable stents across Europe.

2023: Abbott introduced a cutting-edge AI navigation tool for vascular procedures.

2023: Medtronic secured CE Mark approval for a novel drug-coated balloon for below-the-knee PAD.

FAQs:

1) What is the current market size of the Global Interventional Cardiology and Peripheral Vascular Devices Market?

The market was valued at USD 17.4 billion in 2023.

2) What is the major growth driver of the Global Interventional Cardiology and Peripheral Vascular Devices Market?

The major driver is the rising global prevalence of cardiovascular diseases and advancements in minimally invasive devices.

3) Which is the largest region during the forecast period in the Global Interventional Cardiology and Peripheral Vascular Devices Market?

North America is projected to remain the largest region during the forecast period.

4) Which segment accounted for the largest market share in Global Interventional Cardiology and Peripheral Vascular Devices Market?

The coronary stents segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Interventional Cardiology and Peripheral Vascular Devices Market?

Key players include Abbott Laboratories, Boston Scientific, Medtronic, Terumo, B. Braun, Cordis, Biotronik, and BD.

Let me know if you'd like a downloadable version of this summary or a specific visual (e.g., market segmentation chart).